Home › Funds › Capital World Investors › VRTX

Capital World Investors position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Capital World Investors reported holding 25,966,793 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$13.58B, representing 1.66% of its reported portfolio and ranking #14 among its reported holdings. Capital World Investors has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)25.97M sh
Reported value held$13.58B
Portfolio Weight1.66%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Capital World Investors's VRTX position evolved

Capital World Investors first disclosed a stake in VRTX in Q3 2023 at 17,981,667 shares (US$6.25B). The position peaked in Q1 2025 at 28,533,308 shares, worth US$13.83B. Across 13 filings, Capital World Investors increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 25,966,793 shares valued at US$13.58B — a reduction of -148,221 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 17.98M $6.25B New
Q4 2023 21.81M $8.87B Add
Q1 2024 25.57M $10.69B Add
Q2 2024 26.71M $12.52B Add
Q3 2024 26.81M $12.47B Hold
Q4 2024 28.33M $11.41B Add
Q1 2025 28.53M $13.83B Add
Q2 2025 28.73M $12.79B Add
Q3 2025 25.91M $10.15B Reduce
Q4 2025 25.51M $11.57B Reduce
Q1 2026 25.37M $11.33B Reduce
Q2 2026 26.12M $12.97B Add
Q3 2026 25.97M $13.58B Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 31 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B), Capital Research Global Investors (US$9.31B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Capital World Investors held VRTX?

Capital World Investors has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Capital World Investors's current position in VRTX?

As of Q3 2026, Capital World Investors holds 25.97M shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $13.58B, representing 1.66% of its reported portfolio and ranking #14.

Has Capital World Investors been buying or selling VRTX?

In the latest 13F filing (Q3 2026), Capital World Investors reduced its position in VRTX. The position peaked in Q1 2025 at 28.53M shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital Research Global Investors, Capital Research Global Investors, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.